COMPANY
X-Therma
Funding and NIH signals
- NIH award NIH awarded $1.1M (SBIR Phase II 2R44DK136396-03, competing renewal, notice Jul 7, 2026). NIH RePORTER 2R44DK136396-03 (Jul 7, 2026)
Evidence (1 event)
- Jul 7, 2026 · NIH RePORTER 2R44DK136396-03
Organization: X-THERMA INC.; City/State: Hercules, CA; Project number: 2R44DK136396-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-07; FY total cost (award amount): 1100001; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: Phase IIB - Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants; Organization type: Domestic For-Profits
- Jul 7, 2026 · NIH RePORTER 2R44DK136396-03
Raises and deals from press releases
- Raise Series B · $22.4M · announced Mar 13, 2024 Company release ↗
Source quote
- Mar 13, 2024 · Company release ↗
“SAN FRANCISCO, March 13, 2024 /PRNewswire/ — X-Therma Inc. , a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series B funding round”
- Mar 13, 2024 · Company release ↗
Timeline
Funding
- Government grant — SBIR: $1.1M (annual award, as published), announced Jul 7, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗
NIH awards 2
- NIH award 5R44DK136396-02 FY2024: $1,015,699 awarded for that fiscal year; activity R44 (SBIR); PI KLINE, MARK A; recipient as written: X-THERMA INC., Hercules, CA. Greatly Extended Subzero Ischemic Storage of Renal source ↗
- NIH award 1R44DK136396-01A1 FY2023: $971,228 awarded for that fiscal year; activity R44 (SBIR); PI KLINE, MARK A; recipient as written: X-THERMA INC., Hercules, CA. Greatly Extended Subzero Ischemic Storage of Renal source ↗